Form D · Other Health Care
Corfigo, Inc.
Montclair, NJ · CIK 0001702709
Offering snapshot reported Jan 8, 2026 · SEC filing
- Reported sold
- $2.39M Offering amount: $2.96M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 17, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 8, 2026 | Initial | $2,388,489 | No comparison | 10 | SEC filing |
| Jul 10, 2019 | Initial | $2,250,000 | No comparison | 15 | SEC filing |
| Dec 11, 2017 | Amendment | $1,250,000 | $200,000vs Apr 7, 2017 | 9 | SEC filing |
| Apr 7, 2017 | Initial | $1,050,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-569315
13(a) and 13(b) also includes the conversion of approximately $2,293,515 in previously issued convertible notes and accrued interest.
Source: Form D, filed Jan 8, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Doyle | Director |
| Deron B. Siddons | Director, Executive |
| Dr. Jason Sperling | Director, Executive, Promoter |
| Jason Sperling | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
75 Montclair Avenue
Montclair, NJ, 07042
Montclair, NJ, 07042